SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001641489-23-000070
Filing Date
2023-11-09
Accepted
2023-11-09 16:30:31
Documents
70
Period of Report
2023-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q vtvt-20230930.htm   iXBRL 10-Q 978801
2 EX-31.1 vtvt-20230930xexx311.htm EX-31.1 10110
3 EX-31.2 vtvt-20230930xexx312.htm EX-31.2 10323
4 EX-32.1 vtvt-20230930xexx321.htm EX-32.1 4918
5 EX-32.2 vtvt-20230930xexx322.htm EX-32.2 4885
11 GRAHPIC vtvt-20230930_g1.jpg GRAPHIC 144886
  Complete submission text file 0001641489-23-000070.txt   6286197

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT vtvt-20230930.xsd EX-101.SCH 48189
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT vtvt-20230930_cal.xml EX-101.CAL 53263
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT vtvt-20230930_def.xml EX-101.DEF 297608
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT vtvt-20230930_lab.xml EX-101.LAB 630176
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT vtvt-20230930_pre.xml EX-101.PRE 420306
64 EXTRACTED XBRL INSTANCE DOCUMENT vtvt-20230930_htm.xml XML 679796
Mailing Address 3980 PREMIER DR SUITE 310 HIGH POINT NC 27265
Business Address 3980 PREMIER DR SUITE 310 HIGH POINT NC 27265 336-841-0300
vTv Therapeutics Inc. (Filer) CIK: 0001641489 (see all company filings)

IRS No.: 473916571 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37524 | Film No.: 231393066
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences